A cost-efficacy comparison of TNF-inhibitors in the treatment of rheumatoid arthritis

被引：0
|
作者：
Chiou, C
Malone, DC
Wanke, LA
Yu, EB
机构：
[1] Zynx Hlth Inc, Hlth Econ Res, Beverly Hills, CA USA
[2] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[3] Amgen Inc, Hlth Econ & Outcomes Res, Thousand Oaks, CA 91320 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [1] A cost-efficacy comparison of TNF inhibitors in rheumatoid arthritis based on actual dosing in clinical practice
    Chiou, C
    Wanke, LA
    Reyes, E
    Malone, DC
    Yu, EB
    Singh, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 282 - 282
  • [2] COST-EFFICACY ANALYSIS OF TNF ALPHA ANTAGONISTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Gil-Hurle, Dominguez A.
    Ruiz, Costi M.
    Sien, Campo C.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A307 - A307
  • [3] Comparison of the cost-efficacy of biologics in the treatment of rheumatoid arthritis.
    Chiou, CF
    Wanke, LA
    Reyes, C
    Malone, DC
    Ortmeier, BG
    Ofman, JJ
    Weisman, M
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S263 - S263
  • [4] A cost-efficacy comparison of adalimumab and etanercept in the treatment of rheumatoid arthritis
    Malone, DC
    Singh, A
    Wanke, LA
    Ortmeier, BG
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 537 - 537
  • [5] A cost-efficacy comparison of biologic agents in the treatment of rheumatoid arthritis
    Chiou, CF
    Wanke, LA
    Reyes, C
    Malone, DC
    Ortmeier, BG
    Ofman, J
    Weisman, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 353 - 353
  • [6] Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
    Tanaka, Yoshiya
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 319 - 326
  • [7] Cost-efficacy comparison of adalimumab and etanercept in the treatment of rheumatoid arthritis.
    Singh, A
    Wanke, LA
    Malone, DC
    Ortmeier, BG
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S461 - S461
  • [8] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Ingrid Lekander
    Fredrik Borgström
    Jörgen Lysholm
    Ronald F. van Vollenhoven
    Staffan Lindblad
    Pierre Geborek
    Gisela Kobelt
    [J]. The European Journal of Health Economics, 2013, 14 : 863 - 873
  • [9] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Lekander, Ingrid
    Borgstrom, Fredrik
    Lysholm, Jorgen
    van Vollenhoven, Ronald F.
    Lindblad, Staffan
    Geborek, Pierre
    Kobelt, Gisela
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (06): : 863 - 873
  • [10] Treatment of rheumatoid Arthritis in Practice - a Comparison of Tocilizumab vs. TNF-Inhibitors (CONSENS)
    Backhaus, M.
    Kaufmann, J.
    Richter, C.
    Vollmer, M.
    Volberg, C.
    Wassenberg, S.
    Roske, A.
    Hellmann, P.
    Gaubitz, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 119 - 120
12345